Skip to main content
Clinical Trials/NCT03122327
NCT03122327
Unknown
Not Applicable

Comprehensive Geriatric Assessment (cGA) in Newly-diagnosed Elderly Multiple Myeloma (MM) Patients: a Multi-center, Prospective, Non-interventional Study.

Peking Union Medical College Hospital0 sites200 target enrollmentMay 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Myeloma
Sponsor
Peking Union Medical College Hospital
Enrollment
200
Primary Endpoint
Current status of cGA in newly diagnosed elderly MM patients
Last Updated
9 years ago

Overview

Brief Summary

This is a multi-center, prospective, non-interventional study. Eligible newly diagnosed elderly multiple myeloma (MM) patients will receive comprehensive geriatric assessment (cGA) including ECOG scale, questionaires of ADL(activities of daily living), IADL(instrumental ADL),MNA-SF(mini-nutritional assessment), GDS(geriatric depression scale), MMSE(mini-mental state examination), SF-36 and CCI (charlson comorbidity index). Patients will get standard care for MM and receive the above assessments at baseline and after cycle 1, 4 and 12 for treating MM.Follow-up information and survival data of these MM patients would be collected. We would evaluate the cGA status of these newly diagnosed elderly MM patients and investigate the association of cGA parameters with patient's survival.

Detailed Description

Baseline: ECOG, ADL, IADL, MNA-SF, GDS, MMSE, SF-36 and CCI; After cycle 1: ECOG,ADL,IADL,GDS and SF-36 After cycle 4: ECOG,ADL,IADL,GDS, MNA-SF and SF-36 After cycle 12: ECOG,ADL,IADL,GDS, MNA-SF and SF-36

Registry
clinicaltrials.gov
Start Date
May 1, 2017
End Date
May 1, 2022
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jian Li

Associated professor in hematology

Peking Union Medical College Hospital

Eligibility Criteria

Inclusion Criteria

  • age\>=65 years old;
  • newly diagnosed and untreated MM patients;
  • able to provide informed consent

Exclusion Criteria

  • refused to participate;
  • with concomitant amyloidosis;
  • smoldering MM.

Outcomes

Primary Outcomes

Current status of cGA in newly diagnosed elderly MM patients

Time Frame: 12 cycles of MM treatment (about 12 months) after the last patient begins treatment

Description of the cGA (comprehensive geriatric assessment) status of the target population which is currently not known in China. The cGA parameters to be described include baseline ECOG, ADL(activities of daily living), IADL(instrumental ADL),MNA-SF(mini-nutritional assessment), GDS(geriatric depression scale), MMSE(mini-mental state examination), SF-36 and CCI (charlson comorbidity index) which would be carried out by trained physicians. The physicians would receive standard training from geriatricians of Peking Union Medical College Hospital. Moreover, as the treatment for MM (multiple myeloma) patients continues, re-evaluation of the cGA parameters would be done. The status of ECOG, ADL, IADL, GDS, SF-36 would be re-evaluated after cycle 1, 4, 12 of MM treatment. And MNA-SF scale would be re-assessed after cycle 4 and 12 of MM treatment. A description of the changes of the above scales would also be recorded for these MM patients.

Secondary Outcomes

  • Association between the baseline cGA parameters and patients' overall survival(5 years after the last patient begins treatment for MM)
  • Association between baseline cGA parameters and patients' progression free survival(5 years after the last patient begins treatment for MM)

Similar Trials